BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PBX1, P40424, 5087
14 results:

  • 1. Interplay between ceRNA and Epigenetic Control of microRNA: Modelling Approaches with Application to the Role of Estrogen in Ovarian cancer.
    Huang TW; Cheng FHC; Yan CS; Chuang YM; Cho CH; Lai HC; Shieh SF; Chan MWY; Tsai JC
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216394
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-pbx1 and β-catenin-ABCG2 signaling.
    Fang CH; Lin YT; Liang CM; Liang SM
    J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question.
    Scorsetti M; Comito T; Franceschini D; Franzese C; Prete MG; D'Alessio A; Bozzarelli S; Rimassa L; Santoro A
    Br J Radiol; 2020 Feb; 93(1106):20190627. PubMed ID: 31825664
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CA125 over-release behavior following a 75-g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer.
    He Y; Gu Z; Zhu Q; Chen M; He C; Huang Y; Li Q; Di W
    Int J Cancer; 2019 Sep; 145(6):1690-1700. PubMed ID: 30807642
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ovarian cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor pbx1.
    Jung JG; Shih IM; Park JT; Gerry E; Kim TH; Ayhan A; Handschuh K; Davidson B; Fader AN; Selleri L; Wang TL
    Cancer Res; 2016 Nov; 76(21):6351-6361. PubMed ID: 27590741
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Myoepithelioma of the ovary: first reported case.
    Houghton OP; Sumathi VP; Loyson SA; McCluggage WG
    Int J Gynecol Pathol; 2014 Mar; 33(2):191-6. PubMed ID: 24487475
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
    Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
    Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prevalence and incidence of comorbidities in elderly women with ovarian cancer.
    Chia VM; O'Malley CD; Danese MD; Lindquist KJ; Gleeson ML; Kelsh MA; Griffiths RI
    Gynecol Oncol; 2013 May; 129(2):346-52. PubMed ID: 23422502
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of pbx1 target genes in cancer cells by global mapping of pbx1 binding sites.
    Thiaville MM; Stoeck A; Chen L; Wu RC; Magnani L; Oidtman J; Shih IeM; Lupien M; Wang TL
    PLoS One; 2012; 7(5):e36054. PubMed ID: 22567123
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of Meis1 in mitochondrial gene transcription of pancreatic cancer cells.
    Tomoeda M; Yuki M; Kubo C; Yoshizawa H; Kitamura M; Nagata S; Nishizawa Y; Tomita Y
    Biochem Biophys Res Commun; 2011 Jul; 410(4):798-802. PubMed ID: 21703237
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells.
    Erkan M; Weis N; Pan Z; Schwager C; Samkharadze T; Jiang X; Wirkner U; Giese NA; Ansorge W; Debus J; Huber PE; Friess H; Abdollahi A; Kleeff J
    Mol Cancer; 2010 Apr; 9():88. PubMed ID: 20416094
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.
    Park JT; Shih IeM; Wang TL
    Cancer Res; 2008 Nov; 68(21):8852-60. PubMed ID: 18974129
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients.
    Gartner W; Mineva I; Daneva T; Baumgartner-Parzer S; Niederle B; Vierhapper H; Weissel M; Wagner L
    Hum Genet; 2005 Jul; 117(2-3):143-53. PubMed ID: 15841388
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?
    Amthauer H; Ruf J; Böhmig M; Lopez-Hänninen E; Rohlfing T; Wernecke KD; Plöckinger U; Gutberlet M; Lemke AJ; Steinmüller T; Wiedenmann B; Felix R
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):342-8. PubMed ID: 14652697
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.